Advisory
GB is an advisor to buy-side and sell-side clients. Our council is informed by years on the ground in China and by experiences from our consulting and research work.

Buy-side
GB provides assistance during deal planning and execution, and helps to create post-deal success. Our ability to understand the value of a business in China before a deal, as well as our capability of setting appropriate benchmarks and milestones for a business after a deal is a key differentiator for our firm. We partner with our clients to increase the probability that a deal will be successfully consummated, and work to maximize the value that a deal will ultimately create.

Sell-side
GB helps businesses to raise capital and provides advice to companies receiving overtures from potential acquirers. We help clients position themselves appropriately for transactions and we understand the unique issues that Chinese companies face during transactions.

For further information, contact us at advisory@generalbiologic.com

Deal sourcing
GB has unparalleled deal sourcing capabilities in China. We constantly screen deals of a variety of sizes and stages, from concept stage, scientific startups to State Owned Enterprise privatizations and pre-IPOs. GBI, our information business, provides us an advanced and proprietary research platform to screen potential investment targets for our clients with rapidity and accuracy. We present investment opportunities to our clients in a systematic manner through our dealbook system.

For further information, contact us at advisory@generalbiologic.com.